Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Astra discloses novel neuronal N-type calcium channel ligands

Feb. 16, 1999

New agents for prion diseases available for licensing from NIH

Feb. 16, 1999

Promising results obtained with activated immune cell therapies in development at Proneuron

Feb. 15, 1999

New formulation of Zofran receives marketing clearance in the U.S.

Feb. 15, 1999

Mitsubishi antidepressant to be codeveloped by Taisho

Feb. 12, 1999

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

Astra describes N-type neuronal calcium channel blockers and their use

Feb. 12, 1999

Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.

Feb. 12, 1999

OT-7100, a novel analgesic compound for the treatment of peripheral neuropathic pain

Feb. 11, 1999

Potassium channel modulators claimed for dementia by Bayer

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...